|Articles|May 1, 2001
Supplements and Featured Publications
- Artherosclerosis: Achieving Optimal Outcomes in Statin Therapy
- Volume 7
- Issue 5 Suppl
Should All Patients with Cardiovascular Disease Receive Statin Therapy?
Author(s)Robert Vogel, MD, Ernst Schaefer, MD
Advertisement
Articles in this issue
about 25 years ago
Participating Facultyabout 25 years ago
Introductionabout 25 years ago
Threshold Level or Not for Low-Density Lipoprotein Cholesterolabout 25 years ago
Statins--Differences and Similaritiesabout 25 years ago
What Do the Statin Trials Tell Us?about 25 years ago
Surrogate Endpoints and Newer Risk Markers in Atherosclerosis Managementabout 25 years ago
New Therapies on the Horizonabout 25 years ago
A New Statin: A New StandardAdvertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
Incretin Innovation, Metabolic Liver Disease, and Cardiovascular Risk Reduction Dominate ADA 2026
2
EHA 2026 Late Breakers Deliver Practice-Shifting Phase 3 Data and Novel CAR T Approaches Across Hematology
3
Paul Richardson, MD, Calls Mezigdomide “CAR T in a Pill” for Patients With R/R Multiple Myeloma
4
MRD-Guided CLL Treatment Duration: Personalization or Malpractice?
5